Our eye drops have successfully passed the first preclinical stage!

We are thrilled to announce that our eye drops have successfully passed the first preclinical stage. Our dedicated team has worked tirelessly to develop this innovative medication that is now demonstrating promising results in terms of safety and overall performance. We look forward to advancing to the next stage of development. we are proud of the progress we have made towards creating a brighter future for dogs suffering from dry eye disease and ocular surface inflammation.

Previous
Previous

Big Wins for OcuDel Founders at the SETU Research Excellence Awards

Next
Next

5 Common Types of Eye Discharge in Dogs